One of the major trends in the anti-neprilysin market is the increasing prevalence of heart failure worldwide. As per the American Heart Association, over 6 million adults in the U.S. suffer from heart failure. The condition is more common among elderly people. With rising life expectancy, the number of people suffering from heart failure is expected to increase significantly in future, thereby driving the demand for anti-neprilysin drugs for its treatment and management.

The anti-neprilysin market iswitnessinghigh growth owing to the rising prevalence of heart failure across the globe. As per stats, nearly 6.2 million American adults suffer from heart failure. Rising geriatric population is another factor contributing to the growth of this market as aged people are more susceptible to chronic heart conditions. Moreover, drugmakers are actively investing in R&D activities to develop better anti-neprilysin drugs with improved efficacy and safety profiles which is bolstering market expansion.

The global anti-neprilysin market is expected to witness high growth, exhibiting CAGR of 4.6% over the forecast period, due to increasing geriatric population suffering from chronic heart ailments.

Regionally, North America accounts for the largest share in the anti-neprilysin market due to growing prevalence of heart diseases. Europe holds second largest market share owing to rising healthcare spending. Asia Pacific exhibits potential growth due to improving access to healthcare facilities.

read more

https://healthcarelatesteditionnews.blogspot.com/2023/11/pharmaceutical-segment-is-largest.html